Overview
Bio-pharma, comprising vaccines, therapeutics and diagnostics, is the largest sub-sector
contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89 billion). The
biotechnology industry in India, comprising about 800 companies, is expected to be valued at
US$ 11.6 billion in 2017. Indian biotechnology industry reached USD 11.6 bn by FY17 while
growing at a CAGR of 20.3% during FY05-17. It witnessed the y.o.y. the growth of 57.1% in
FY17 compared to the previous financial year.
International Standing
India is ranked 12th in the world in Biotech and third in Asia-Pacific. India has the second-highest number of US Food and Drug Administration (USFDA)–approved plants, after the USA. The Indian biotech industry holds about 2 per cent share of the global biotech industry. The high demand for different biotech products has also opened up scope for the foreign companies to set up base in India. The biotechnology industry in India comprises of about 800 companies and stands amongst the top 12 biotech destinations in the world.
Industry Forecast
India's Biotechnology industry comprising Bio-pharmaceuticals, Bio-services, Bio-agriculture,
and Bioinformatics is expected grow at an average growth rate of around 30 per cent a year and
reach US$ 100 billion by 2025.
INDIAN Biotech INDUSTRY AT A Glance IN 2016 - 2017